Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.39 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.39 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.39 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28719 | 1.00 | ALDH1A1 (0.52) | ALDH1A1SMN1; SMN2CYP2C9CYP2C19CYP3A4 | |
| SCHEMBL209153 | 1.00 | ALDH1A1 (0.52) | ALDH1A1SMN1; SMN2CYP2C9CYP2C19CYP3A4 | |
| SCHEMBL15492440 | 1.00 | ALDH1A1 (0.52) | ALDH1A1SMN1; SMN2CYP2C9CYP2C19CYP3A4 | |
| SCHEMBL25118469 | 1.00 | ALDH1A1 (0.52) | ALDH1A1SMN1; SMN2CYP2C9CYP2C19CYP3A4 | |
| SCHEMBL1059882 | 1.00 | ALDH1A1 (0.52) | ALDH1A1SMN1; SMN2CYP2C9CYP2C19CYP3A4 | |
| SCHEMBL25434872 | 1.00 | ALDH1A1 (0.52) | ALDH1A1SMN1; SMN2CYP2C9CYP2C19CYP3A4 | |
| SCHEMBL20375020 | 1.00 | ALDH1A1 (0.52) | ALDH1A1SMN1; SMN2CYP2C9CYP2C19CYP3A4 | |
| SCHEMBL24079397 | 1.00 | ALDH1A1 (0.52) | ALDH1A1SMN1; SMN2CYP2C9CYP2C19CYP3A4 | |
| SCHEMBL13452762 | 0.98 | ALDH1A1 (0.50) | ALDH1A1SMN1; SMN2CYP2C9CYP2C19CYP3A4 | |
| SCHEMBL28961005 | 0.98 | ALDH1A1 (0.50) | ALDH1A1SMN1; SMN2CYP2C9CYP2C19CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 163 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9932432-B2 | Polymers of maleimide and cycloolefinic monomers as permanent dielectric materials | PROMERUS, LLC (US) | 2018-04-03 | — | — | US | claimed |
| WO-2016179452-A1 | POLYMERS OF MALEIMIDE AND CYCLOOLEFINIC MONOMERS AS PERMANENT DIELECTRIC MATERIALS | PROMERUS, LLC (US) | 2016-11-10 | — | — | WO | claimed |
| US-20160326292-A1 | POLYMERS OF MALEIMIDE AND CYCLOOLEFINIC MONOMERS AS PERMANENT DIELECTRIC MATERIALS | SUMITOMO BAKELITE CO., LTD. (JP) | 2016-11-10 | — | — | US | claimed |
| EP-1817376-B1 | HYBRID THERMOSETTING COMPOSITION | 3M INNOVATIVE PROPERTIES CO (US) | 2012-08-22 | — | — | EP | claimed |
| EP-1817353-A1 | BRANCHED POLYMER | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2007-08-15 | — | — | EP | claimed |
| EP-1817376-A1 | HYBRID THERMOSETTING COMPOSITION | 3M Innovative Properties Company (US) | 2007-08-15 | — | — | EP | claimed |
| WO-2006060092-A1 | HYBRID THERMOSETTING COMPOSITION | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2006-06-08 | — | — | WO | claimed |
| WO-2006060086-A1 | BRANCHED POLYMER | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2006-06-08 | — | — | WO | claimed |
| US-20060116492-A1 | Branched polymer | 3M INNOVATIVE PROPERTIES COMPANY | 2006-06-01 | — | — | US | claimed |
| US-20060116476-A1 | Hybrid thermosetting composition | 3M INNOVATIVE PROPERTIES COMPANY | 2006-06-01 | — | — | US | claimed |
| US-12476201-B2 | Method for manufacturing electronic component, resin composition for temporary protection, and resin film for temporary protection | SHOWA DENKO MATERIALS CO LTD (JP) | 2025-11-18 | — | — | US | disclosed |
| CN-120044752-A | Photosensitive resin composition | 东京应化工业株式会社 | 2025-05-27 | — | — | CN | disclosed |
| CN-120044751-A | Photosensitive resin composition | 东京应化工业株式会社 | 2025-05-27 | — | — | CN | disclosed |
| CN-112930584-B | Method for manufacturing semiconductor device and adhesive film for processing semiconductor wafer | 株式会社力森诺科 | 2024-11-15 | — | — | CN | disclosed |
| CN-110317174-B | Hydrogen barrier agent, composition for forming hydrogen barrier film, method for producing hydrogen barrier film, and electronic device | 东京应化工业株式会社 | 2024-10-22 | — | — | CN | disclosed |
| US-20040235849-A1 | Tetrahydroquinoxalines acting as bradykinin antagonists | BAYER HEALTHCARE AG (DE) | 2004-11-25 | — | — | US | disclosed |
| EP-1411948-A1 | TETRAHYDROQUINOXALINES ACTING AS BRADYKININ ANTAGONISTS | Bayer Aktiengesellschaft (DE) | 2004-04-28 | — | — | EP | disclosed |
| US-20040032547-A1 | Optical film and display system | NITTO DENKO CORPORATION (JP) | 2004-02-19 | — | — | US | disclosed |
| WO-2003007958-A1 | TETRAHYDROQUINOXALINES ACTING AS BRADYKININ ANTAGONISTS | BAYER HEALTHCARE AG (DE) | 2003-01-30 | — | — | WO | disclosed |
| EP-1160591-A1 | TRANSPARENT FILM | Kaneka Corporation (JP) | 2001-12-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040235849-A1 | Tetrahydroquinoxalines acting as bradykinin antagonists | BDKRB2, BDKRB1, LTB4R2 | ALDH1A1 4292/4885SMN1; SMN2 3726/4885CYP2C9 1755/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.